Effectiveness of omalizumab in monozygotic twin sisters with severe allergic asthma.
Just
J
J
Centre d'Investigation de l'Asthme et des Allergies Hôpital d'Enfants Armand Trousseau 75012 Paris France. jocelyne.just@trs.aphp.fr
Sahraoui
F
F
Le Gros
V
V
Grimfeld
A
A
D000730:Androstadienes / Q000627:therapeutic use; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy*; D001827:Body Height / Q000187:drug effects; D002648:Child; D004311:Double-Blind Method; D005260:Female; D000068298:Fluticasone; D006801:Humans; D000069444:Omalizumab; D014430:Twins, Monozygotic
D000730:Androstadienes; D018926:Anti-Allergic Agents; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D000068298:Fluticasone